iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Down 73.6% in June

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the recipient of a large drop in short interest in the month of June. As of June 30th, there was short interest totaling 3,425 shares, a drop of 73.6% from the June 15th total of 12,988 shares. Based on an average trading volume of 4,287 shares, the days-to-cover ratio is presently 0.8 days. Currently, 2.3% of the company’s stock are sold short.

iShares Neuroscience and Healthcare ETF Stock Performance

Shares of iShares Neuroscience and Healthcare ETF stock traded down $0.84 during midday trading on Monday, reaching $38.21. 4,534 shares of the company’s stock traded hands, compared to its average volume of 2,147. The company has a market cap of $5.73 million, a price-to-earnings ratio of 15.61 and a beta of 0.73. The company’s 50 day simple moving average is $36.08 and its 200 day simple moving average is $33.80. iShares Neuroscience and Healthcare ETF has a 52 week low of $22.41 and a 52 week high of $40.42.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.